LabCompass

Samir B. Kahwash

Medicine · The Ohio State University

Established · publishing since 1996Rising activity

Publications

191

Citations

2,182

Est. group size

~3

Recurring co-author estimate

Active years

31

Publishing since 1996

Research summary
AI-generated

Samir B. Kahwash is a pediatric pathologist whose work centers on diagnosing blood and bone marrow disorders in children, including leukemias, lymphomas, and other hematologic conditions, often through detailed case reports and morphological analysis of blood cells. His research also contributes to larger multi-institutional studies on pediatric acute myeloid leukemia treatment protocols through the Children's Oncology Group. This work would suit students interested in pediatric hematopathology, diagnostic blood cell morphology, or clinical trial-based cancer research in children.

Pediatric hematopathologyAcute myeloid leukemia in childrenLymphoma diagnosis and case studiesBlood cell morphology and diagnosticsPediatric oncology clinical trials

Publication output has fluctuated over the past decade with a notable spike in 2023, but has remained fairly steady overall, averaging about 11 papers per year over the last five years.

Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026

Publication cadence
Publications per year over the last 10 years — averaging 11.4/year recently
2017: 14 publications172018: 5 publications182019: 9 publications192020: 11 publications202021: 8 publications212022: 6 publications222023: 26 publications26232024: 12 publications242025: 11 publications252026: 2 publications26
Recent publications
Publishes in
  • Ibnosina Journal of Medicine and Biomedical Sciences×19
  • Blood×10
  • PubMed×10
  • Pediatric and Developmental Pathology×9
  • Pediatric Blood & Cancer×4
Similar researchers
By research-topic overlap

This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.

Last updated Jul 19, 2026.

Claim or correct this profile